Complement and Immune Complexes
Serum sickness resulting from repeated administration of horse antitoxins was hypothesized to be an immune complex disease by von Pirquet and Schick at the turn of this century (1 ). Arthus developed the first animal model of immune complex disease by inducing cutaneous vasculitis and inflammation following injection of antigen in immunized rabbits (2 ). In the 1940s Heidel-berger observed that complement inhibited the formation of precipitating antigen-antibody lattices. In the 1950s and 1960s, experimental serum sickness models of glomerulonephritis and vasculitis demonstrated the potential for circulating immune complexes to cause disease (3 ,4 ).
- 改良過碘酸鈉標記法制備酶標抗體
- 基因調節元件的測繪和分析技術
- 巴傲得生物-WB實驗流程
- 染色質免疫沉淀芯片(Chip-Chip)
- 免疫球蛋白分子
- 熒光二抗如何選擇更好-根據一抗種屬及類型
- Site-Directed Mutagenesis of Antibody-Variable Regions
- RNase H: Specificity, Mechanisms of Action, and Antiviral Target
- Innate Immune Function of Eosinophils: From Antiparasite to Antitumor Cells
- Fusion?is?an?important?procedure?to?produce?monoclonal?antibodies?(MoAb).